Instituto de Investigación Biomédica de Salamanca
In research, Instituto de Investigación Biomédica de Salamanca stands highest in Medicine (#2,352 of 10,443 worldwide), Health Sciences (#2,923 of 11,982 worldwide) and Life Sciences (#2,696 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology and Oncology — Hematology is 17.5× its share of world research.
- World rank, 2022–2025
- #5,471 of 28,054 · #8,578 all time
- Rank in Spain
- #146 of 658
- Research works
- 1.4k ▲ 44% vs 2013–17
- Citations
- 24k 17.1 per fractional work
- Top-10% rate
- 18.3% record average 16.5%
- Open access
- 63% world 28%
What is Instituto de Investigación Biomédica de Salamanca known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #2,352 of 10,443 | 17.0% | 296 | #3765 | |
| Health SciencesDomain | #2,923 of 11,982 | 17.4% | 317 | #4745 | |
| Life SciencesDomain | #2,696 of 7,800 | 21.5% | 126 | #4139 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,620 of 3,579 | 23.3% | 63 | #4456 |
Each strip is that field’s whole ranked pool, with the notch where Instituto de Investigación Biomédica de Salamanca sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#3,765 #2,352
- Health Sciences#4,745 #2,923
- Life Sciences#4,139 #2,696
- Biochemistry, Genetics and Molecular Biology#4,456 #2,620
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Instituto de Investigación Biomédica de Salamanca specialise in?
Where its research is concentrated relative to its size: Hematology takes 17.5× the share of its output that it takes of world research.
- HematologySubfield · 26.5 works18×
- OncologySubfield · 33.1 works5.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.7×. Every wedge is a field page.
- Immunology and Microbiology 4.7×
- Medicine 3.1×
- Neuroscience 3.0×
- Veterinary 3.0×
- Biochemistry, Genetics and Molecular Biology 2.4×
- Pharmacology, Toxicology and Pharmaceutics 2.1×
- Dentistry 1.4×
- Nursing 1.1×
- Health Professions 1.0×
- Psychology 0.8×
- Chemistry 0.6×
- Agricultural and Biological Sciences 0.5×
- Mathematics 0.3×
- Economics, Econometrics and Finance 0.2×
- Computer Science 0.2×
- Environmental Science 0.2×
- Materials Science 0.2×
- Decision Sciences 0.2×
- Engineering 0.1×
- Social Sciences 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.1×
- Business, Management and Accounting 0.1×
- Energy 0.0×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at Instituto de Investigación Biomédica de Salamanca?
Ranked on the composite score, Alejandro Martı́n, María‐Victoria Mateos and Enrique M. Ocio lead among researchers whose main affiliation is Instituto de Investigación Biomédica de Salamanca.
- 1 Alejandro Martı́n · #111,321 worldwide 157 citations · 63 works
- 2 María‐Victoria Mateos · #113,055 worldwide 649 citations · 165 works
- 3 Enrique M. Ocio · #209,296 worldwide 180 citations · 62 works
- 4 Fermín Sánchez‐Guijo · #398,880 worldwide 91 citations · 38 works
- 5 Lucía López‐Corral · #509,349 worldwide 73 citations · 45 works
- 6 Ignacio Cruz‐González · #554,833 worldwide 175 citations · 85 works
- 7 José Ramón González‐Porras · #647,949 worldwide 33 citations · 20 works
- 8 Noemí Puig · #725,480 worldwide 71 citations · 47 works
- 9 Miguel Alcoceba · #780,359 worldwide 41 citations · 27 works
- 10 Pedro L. Sánchez · #849,367 worldwide 112 citations · 86 works
Which keywords describe research at Instituto de Investigación Biomédica de Salamanca?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Prognostic Factors, Inflammation, Chemotherapy, Treatment, Minimal Residual Disease, Diagnosis and Rituximab.
- Tumor Regression
- Leukemia
- Genomic Aberrations
- Nephrotoxicity
- Helminth Infections
- Cancer Immunotherapy
- Targeted Therapy
- Tumor Microenvironment
- Guidelines
- Prognosis
- Clinical Trials
- International Myeloma Working Group
- Lymphoma
- Proteasome Inhibitors
- Minimal Residual Disease
- Immunotherapy
- Cancer
- Chemotherapy
- Prognostic Factors
- Inflammation
- Epidemiology
- Treatment
- Quality of Life
- Diagnosis
- Oxidative Stress
- Biomarkers
- Rituximab
- Staging System
- Diagnosis Criteria
- Cancer Therapy
- Hematopoietic Stem Cells
- Aging
- Chronic Kidney Disease
- PET Imaging
- Therapeutic Targets
- Health-related Quality of Life
- Hearing Loss
- Chronic Lymphocytic Leukemia
- Molecular Profiling
- Immunomodulation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology47▲ 2.4×108 topics
- Inflammation28▲ 2.6×69 topics
- Treatment22▲ 3.6×43 topics
- Prognostic Factors22▲ 9.8×13 topics
- Quality of Life20▲ 2.7×35 topics
- Chemotherapy19▲ 5.4×23 topics
- Diagnosis18▲ 3.8×36 topics
- Cancer18▲ 2.6×47 topics
- Oxidative Stress17▲ 2.1×46 topics
- Immunotherapy14▲ 4.0×18 topics
- Biomarkers14▲ 4.0×16 topics
- Minimal Residual Disease14▲ 39×2 topics
- Rituximab13▲ 17×4 topics
- Proteasome Inhibitors12▲ 36×2 topics
- Staging System12▲ 38×2 topics
- Lymphoma12▲ 14×4 topics
- Diagnosis Criteria11▲ 64×1 topic
- International Myeloma Working Group11▲ 64×1 topic
- Cancer Therapy11▲ 3.9×17 topics
- Clinical Trials11▲ 3.3×18 topics
- Hematopoietic Stem Cells10▲ 23×3 topics
- Prognosis10▲ 6.0×8 topics
- Aging9▲ 3.5×15 topics
- Guidelines9▲ 4.0×12 topics
- Chronic Kidney Disease9▲ 7.6×8 topics
- Tumor Microenvironment9▲ 4.1×7 topics
- PET Imaging9▲ 10×4 topics
- Targeted Therapy9▲ 7.8×5 topics
- Therapeutic Targets8▲ 11×6 topics
- Cancer Immunotherapy8▲ 11×3 topics
- Health-related Quality of Life7▲ 6.1×5 topics
- Helminth Infections7▲ 37×2 topics
- Hearing Loss7▲ 12×4 topics
- Nephrotoxicity7▲ 32×2 topics
- Chronic Lymphocytic Leukemia7▲ 30×1 topic
- Genomic Aberrations7▲ 30×1 topic
- Molecular Profiling7▲ 13×3 topics
- Leukemia6▲ 15×2 topics
- Immunomodulation6▲ 9.6×5 topics
- Tumor Regression6▲ 11×2 topics
Which research topics does Instituto de Investigación Biomédica de Salamanca publish most on?
By volume in 2022–2025: Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research and Acute Myeloid Leukemia Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Myeloma Research and TreatmentsHematology 11 works
- 2 Chronic Lymphocytic Leukemia ResearchGenetics 7 works
- 3 CAR-T cell therapy researchOncology 6 works
- 4 Acute Myeloid Leukemia ResearchHematology 6 works
- 5 Lymphoma Diagnosis and TreatmentPathology and Forensic Medicine 5 works
- 6 Acute Kidney Injury ResearchNephrology 4 works
- 7 Cardiac Valve Diseases and TreatmentsCardiology and Cardiovascular Medicine 4 works
- 8 Parasites and Host InteractionsParasitology 4 works
- 9 Lung Cancer Diagnosis and TreatmentPulmonary and Respiratory Medicine 4 works
- 10 Cancer Immunotherapy and BiomarkersOncology 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instituto de Investigación Biomédica de Salamanca's research output changed?
Output in 2018–2022 was 44% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Salamanca
- Universidad de Salamanca
- Complejo Hospitalario de Salamanca
- Universidad Pontificia de Salamanca
- Centro de Investigación del Cáncer
- Instituto de Recursos Naturales y Agrobiología de Salamanca
- Asociación Universitaria Iberoamericana de Postgrado
- Red Temática de Investigación Cooperativa en Cáncer
- Itelsa (Spain)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.